<!DOCTYPE html>
<html>
<head>
  <meta charset="utf-8">
  <title>Why DexCom (DXCM) Shares Are Sliding Today</title>
</head>
<body>
  <a href="../../index.html">← Back to home</a>
  <h1>Why DexCom (DXCM) Shares Are Sliding Today</h1>
  <ul>
<li>DexCom is up 0.8% since the beginning of the year, but at $79.17 per share, it is still trading 12.8% below its 52-week high of $90.75 from February 2025.</li>
<li>In addition to the downgrade, Oppenheimer also removed its $102 price target for the medical device maker.</li>
<li>What Is The Market Telling Us DexCom’s shares are somewhat volatile and have had 14 moves greater than 5% over the last year.</li>
<li>The previous big move we wrote about was 4 days ago when the stock gained 3.3% on the news that company executives provided an optimistic outlook at the Wells Fargo Healthcare Conference.</li>
<li>Investors who bought $1,000 worth of DexCom’s shares 5 years ago would now be looking at an investment worth $813.64.</li>
<li>Shares of medical device company DexCom (NASDAQ:DXCM) fell 2% in the morning session after Oppenheimer downgraded the stock to Perform from a previous Outperform rating.</li>
<li>What Happened?</li>
</ul>
<p><a href="https://finance.yahoo.com/news/why-dexcom-dxcm-shares-sliding-154557286.html">Source</a> · 2025-09-08T15:45:57+00:00</p>
</body>
</html>